SEC Form 4 · accession 0001123292-16-003076
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Flynn
Director
Period of report
Dec 16, 2016
Accepted (ET)
Dec 19, 2016 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 16, 2016 | P | 800 | $6.705 | A | 800 | D |
Table II — derivative securities
No Table II lines on this filing.